Who owns IMMUNEERING CORP - CLASS A?
- Ticker: IMRX
- CUSIP Number: 45254e107
Tip: Access positions for across all investors
Analyze quarterly positions in Immuneering Corp - Class A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Immuneering Corp - Class A stock
Who bought or sold IMMUNEERING CORP - CLASS A this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.1M | $2.3M | -1% | Dec 2024 |
|
T. Rowe Price Associates | 767k | $1.7M | -5% | Dec 2024 |
|
Morgan Stanley | 454k | $908k | 1% | Dec 2024 |
|
BlackRock | 319k | $701k | 0% | Dec 2024 |
|
Southport Management | 215k | $473k | 5% | Dec 2024 |
|
Geode Capital Management | 208k | $459k | -1% | Dec 2024 |
|
Rockefeller Capital Management | 177k | $390k | 100% | Dec 2024 |
|
TD Asset Management | 151k | $332k | 0% | Dec 2024 |
|
Millennium Management | 103k | $227k | -58% | Dec 2024 |
|
Manufacturers Life Insurance Company | 83k | $182k | 0% | Dec 2024 |
|
State Street Corporation | 79k | $173k | 13% | Dec 2024 |
|
HighTower Advisors | 71k | $157k | 34% | Dec 2024 |
|
CI Private Wealth | 64k | $140.228000 | 0% | Dec 2024 |
|
Exchange Traded Concepts | 58k | $128k | 0% | Dec 2024 |
|
UBS Group | 53k | $116k | 66% | Dec 2024 |
|
Bridgeway Capital Management | 51k | $113k | 77% | Dec 2024 |
|
Two Sigma Investments | 51k | $111k | 25% | Dec 2024 |
|
Tidemark | 44k | $98k | -14% | Dec 2024 |
|
Northern Trust | 40k | $87k | 0% | Dec 2024 |
|
XTX Topco | 33k | $72k | 177% | Dec 2024 |
|
First Manhattan | 32k | $71k | 100% | Dec 2024 |
|
Bank of America Corporation | 31k | $68k | -1% | Dec 2024 |
|
Marshall Wace | 21k | $47k | 100% | Dec 2024 |
|
Pnc Financial Services | 20k | $44k | 0% | Dec 2024 |
|
Point72 Asia | 17k | $38k | -2% | Dec 2024 |
|
Man Group | 14k | $31k | 1% | Dec 2024 |
|
Dimensional Fund Advisors | 13k | $29k | 0% | Dec 2024 |
|
Tang Capital Management | 12k | $27k | 100% | Dec 2024 |
|
JustInvest | 12k | $26k | 100% | Dec 2024 |
|
Vontobel Holding | 10k | $22k | 0% | Dec 2024 |
|
Corsair Capital Management | 10k | $22k | 0% | Dec 2024 |
|
Atlantic Trust | 10k | $20k | 0% | Dec 2024 |
|
Barclays | 9.9k | $22k | 0% | Dec 2024 |
|
Federated Investors | 3.8k | $8.4k | -25% | Dec 2024 |
|
Tower Research Capital | 2.4k | $5.3k | 22% | Dec 2024 |
|
Citigroup | 2.3k | $5.1k | 189% | Dec 2024 |
|
Jpmorgan Chase & Co | 2.0k | $4.3k | -19% | Dec 2024 |
|
Cubist Systematic Strategies | 659.00 | $1.4k | 0% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 349.00 | $768.009400 | 100% | Dec 2024 |
|
EverSource Wealth Advisors | 345.00 | $759.000000 | 0% | Dec 2024 |
|
SBI Securities | 74.00 | $162.999800 | 100% | Dec 2024 |
|
Point72 | 16.00 | $35.000000 | 0% | Dec 2024 |
|
Who sold out of Immuneering Corp - Class A?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Prosight Management | Sep 2024 | 190k | $473k |
Qube Research & Technologies | Sep 2024 | 15k | $37k |
Mirae Asset Global Etfs Holdings | Jun 2024 | 11k | $15k |
Royal Bank of Canada | Sep 2024 | 11k | $38k |
Catalyst Funds Management Pty | Jun 2024 | 5.6k | $7.2k |